Page last updated: 2024-11-02

oxidopamine and Marasmus

oxidopamine has been researched along with Marasmus in 2 studies

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schlesinger, L1
Arevalo, M1
Simon, V1
Lopez, M1
Muñoz, C1
Hernandez, A1
Carreño, P1
Belmar, J1
White, A1
Häffner-Cavaillon, N1
González-Ariki, S1
Husband, AJ1

Other Studies

2 other studies available for oxidopamine and Marasmus

ArticleYear
Immune depression induced by protein calorie malnutrition can be suppressed by lesioning central noradrenaline systems.
    Journal of neuroimmunology, 1995, Volume: 57, Issue:1-2

    Topics: Animals; Brain; Corticosterone; Female; Immune Tolerance; Interleukin-1; Lymphocyte Activation; Medi

1995
Sympathectomy abrogates immunodeficiency associated with protein-energy malnutrition.
    Journal of neuroimmunology, 1999, Sep-01, Volume: 99, Issue:1

    Topics: Animals; Female; Immunoglobulin A; Immunologic Deficiency Syndromes; Injections, Intraperitoneal; In

1999